Pfizer, Sanofi-Aventis, Novartis, GlaxoSmithKline, Abbott Laboratories and Merck to Speak at the 9th Polymorphism & Crystallization Scientific Forum

Pharma IQ News

There has been increased focus on using crystals and the ever-changing, sometimes disappearing properties of polymorphs as significant scientific and business opportunities.  IQPC’s Polymorphism & Crystallization Scientific Forum, taking place October 25- 27, 2010 in Philadelphia, PA will address these issues.

Attendees will hear the latest pharmaceutical research and scientific advances for polymorphism and crystallization. Topics to be discussed at the event include:          

  • Polymorphism patent procurement and protection
  • Developing new strategies to extend product lifecycles
  • Improving pharmaceuticals through co-crystals
  • Positioning R&D teams to deliver more timely solutions
  • Using Innovative analysis techniques to assure quality along the path to development
  • Tablet sticking and picking

The audience for this event comprises of professionals specialising in chemistry, sciences, chemical engineering, physical properties, pre-formulation, drug delivery, pharmaceutics, solid state and toxicology.

Plus, attendees have the opportunity to attend three pre-conference workshops on the following topics:

  • Crystal phase screening, selection and optimisation in early stage drug development
  • Emergence of new crystal phases during late stage development: impact, management prevention
  • Polymorphism as a tool for life cycle extension

The speaker faculty for this event includes: Pfizer, Novartis, Abbott Laboratories, Astrazeneca, GlaxoSmithKline, University of Michigan, Vertex Pharmaceuticals and more.

For more information, visit the website or contact Karen Richardson at or (646) 378-6034.

IQPC produces more than 1,500 events annually around the world, and continues to grow.  Founded in 1973, IQPC now has offices in major cities across five continents.  IQPC leverages a global research base of best practices to produce a cross industry of information-sharing forums.